Antibodies
Bio-Connect offers one of the most comprehensive portfolios of antibodies worldwide.
Human Protein Atlas | Primary Antibodies | MolBoolean | PrEST Control Antigens | IHC | ICC | WB | ChIP | Enhanced Antibody Validation
Atlas Antibodies is the original manufacturer of highly validated primary antibodies and control antigens. The company was founded by researchers from the prestigious Human Protein Atlas project who wanted to make the unique antibodies developed in the project available to fellow researchers worldwide.
Atlas Antibodies manufactures and provides highly validated reagents that enable leading research in biology, pathology, and medicine for the purpose of understanding and improving human health. The primary antibodies portfolio covers different research areas:
Their standardized manufacturing process and the rigorous quality control ensure that the antibodies meet the highest level of specificity and selectivity required for your research to succeed.
Atlas Antibodies’ products are validated for use in IHC, WB and ICC-IF, according to the following protocols: Protocols for Antibody Applications
Enhanced validation is applied as an extra level of security in antibodies validation.
Discover the AtlasPlex kit configurator.
Bio-Connect supplies all their products in the Benelux. If you have any questions, please contact us.
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Antibodies
Olpe C, Khamis D, Chukanova M, et al. A diffusion-like process accommodates new crypts during clonal expansion in human colonic epithelium.
He C, Xu K, Zhu X, et al. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
Schwabenland M, Salié H, Tanevski J, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.
Benito-Kwiecinski S, Giandomenico SL, Sutcliffe M, et al. An early cell shape transition drives evolutionary expansion of the human forebrain.
Teng S, Li YE, Yang M, et al. Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer.
Suh J, Romano DM, Nitschke L, et al. Loss of ataxin-1 potentiates alzheimer’s pathogenesis by elevating cerebral bace1 transcription.
Velasco S, Kedaigle AJ, Simmons SK, et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex.
Mathys H, Davila-Velderrain J, Peng Z, et al. Single-cell transcriptomic analysis of Alzheimer’s disease.
Siles L, Ninfali C, Cortés M, Darling DS, Postigo A. ZEB1 protects skeletal muscle from damage and is required for its regeneration.
Garcia-Bermudez J, Baudrier L, Bayraktar EC, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death.
Atlas Antibodies offers a dedicated Antibody Co-Development Program for researchers who require monoclonal antibodies that are not yet available in their catalog. Through this program, Atlas Antibodies develops a new monoclonal antibody against a selected target using their established antibody generation and validation workflows. Researchers participate in the evaluation and characterization of candidate clones within their own experimental systems, using agreed-upon applications such as immunohistochemistry (IHC), immunofluorescence (IF), flow cytometry, or other relevant methods. When a project is selected, Atlas Antibodies manages the development process and may incorporate the resulting antibody into their commercial portfolio, while collaborators gain early access to an antibody validated for their specific application.
Through Bio-Connect, customers in the Benelux can access the Atlas Antibodies Co-Development Program with local scientific support. Our team helps define the target, applications, and sample types, coordinates the submission and communication with Atlas Antibodies, and supports the collaboration to ensure an antibody is developed and validated for your experimental needs.
We gladly support you by keeping you updated on our latest products and developments
